CYP2D6*4 polymorphism: A new marker of response to hormonotherapy in male breast cancer?

M. Abreu,M. Gomes,F. Menezes,N. Afonso,Pedro Henriques Abreu,R. Medeiros,D. Pereira,C. Lopes
DOI: https://doi.org/10.1016/j.breast.2015.04.010
2015-08-01
Abstract:
What problem does this paper attempt to address?